KalVista Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell KALV and other ETFs, options, and stocks.About KALV
KalVista Pharmaceuticals, Inc. is a clinical stage pharmaceutical company, which engages in the discovery, development, and commercialization of small molecule protease inhibitors for diseases with significant unmet need. Its product candidates are inhibitors of plasma kallikrein being developed for two indications: Sebetralstat for HAE and Factor XIIa.
CEOBenjamin L. Palleiko
CEOBenjamin L. Palleiko
Employees270
Employees270
HeadquartersFramingham, Massachusetts
HeadquartersFramingham, Massachusetts
Founded2004
Founded2004
Employees270
Employees270
KALV Key Statistics
Market cap671.88M
Market cap671.88M
Price-Earnings ratio-3.46
Price-Earnings ratio-3.46
Dividend yield—
Dividend yield—
Average volume650.56K
Average volume650.56K
High today$13.53
High today$13.53
Low today$12.87
Low today$12.87
Open price$13.13
Open price$13.13
Volume578.48K
Volume578.48K
52 Week high$16.32
52 Week high$16.32
52 Week low$7.30
52 Week low$7.30
KALV News
TipRanks 23h
KalVista Pharmaceuticals Updates Stockholder Meeting ScheduleElevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...
Analyst ratings
100%
of 10 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own KALV. This list is generated using Robinhood data, and it’s not a recommendation.